hydroxyproline has been researched along with levonorgestrel in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Everett, M; Hay, AW; Purdie, DW | 1 |
| Di, X; Gu, S; Jiang, J; Li, Y; Zhang, C | 1 |
2 trial(s) available for hydroxyproline and levonorgestrel
| Article | Year |
|---|---|
Short term effects of SHD 386L and levonorgestrel on bone and mineral metabolism in the postmenopause: a double-blind randomised placebo-controlled trial.
Topics: Alkaline Phosphatase; Bone and Bones; Calcium; Creatinine; Double-Blind Method; Estradiol; Female; Follicle Stimulating Hormone; Humans; Hydroxyproline; Levonorgestrel; Luteinizing Hormone; Menopause; Middle Aged; Minerals; Osteocalcin; Osteoporosis, Postmenopausal; Time Factors | 1992 |
Effects of levonorgestrel-releasing subdermal contraceptive implants on bone density and bone metabolism.
Topics: Absorptiometry, Photon; Adult; Bone Density; Calcification, Physiologic; Contraceptive Agents, Female; Creatinine; Drug Implants; Female; Femur; Hematocrit; Humans; Hydroxyproline; Levonorgestrel; Lumbar Vertebrae; Platelet Count; Premenopause; Prospective Studies | 1999 |